Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 102 results for "Myeloproliferative Neoplasms (MPN)".

Thumbnail for Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

MPN - 491

Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

Munira Borhany

Poster Presenter: Munira Borhany

Thumbnail for Concurrent Thrombosis and Hemorrhage in Myeloproliferative Neoplasms: Impact on In-Hospital Outcomes, an NIS-Based Study

MPN - 508

Concurrent Thrombosis and Hemorrhage in Myeloproliferative Neoplasms: Impact on In-Hospital Outcomes, an NIS-Based Study

Ameerdad Khan

Poster Presenter: Ameerdad Khan

Thumbnail for Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

Previous 1...5 6 7 8 9 10 11 12 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MPN - 528

Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

Sharan Jhaveri

Poster Presenter: Sharan Jhaveri

$Thumbnail for The selective PI3Kd inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from naοve and JAK inhibitor-refractory/resistant patients with myelofibrosis$

MPN - 545

The selective PI3Kd inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from naοve and JAK inhibitor-refractory/resistant patients with myelofibrosis

Giusy Di Conza

Poster Presenter: Giusy Di Conza

Thumbnail for Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

MPN - 553

Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

Liang-Chuan Wang

Poster Presenter: Liang-Chuan Wang

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

MPN - 554

Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

Tania Jain

Poster Presenter: Tania Jain

Thumbnail for Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

MPN - 555

Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis

MPN - 556

Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis

John Mascarenhas

Poster Presenter: John Mascarenhas

Thumbnail for Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

MPN - 558

Healthcare Provider Perspectives on the Therapeutic Phlebotomy Workflow in Polycythemia Vera and Associated Resource Use in the United States

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors